Table 2.
Course of COVID-19 disease and comorbidities prior to COVID-19.
| N (%) | Mean | SD | Min | Max | |
|---|---|---|---|---|---|
| Hospitalization | 33 (25.9) | ||||
| • Duration of hospitalization [days] | 14.10 | 19.01 | 1 | 100 | |
| ICU stay | 10 (7.9) | ||||
| • Duration of ICU stay [days] | 10.83 | 5.46 | 5 | 21 | |
| Disease severity according to WHO | |||||
| • Mild/moderate | 91 (71.7) | ||||
| • Severe | 28 (22.0) | ||||
| • Critical | 8 (6.3) | ||||
| O2 therapy during hospitalization | 27 (21.2) | ||||
| Mechanical ventilation | 6 (4.7) | ||||
| Duration between first positive PCR test and rehabilitation admission [days] | 408.81 | 140.89 | 124 | 813 | |
| Duration of rehabilitation [days] | 28.77 | 5.44 | 9 | 42 | |
| Comorbidities prior to COVID-19 | |||||
| • Hypertension | 38 (29.9) | ||||
| • Coronary heart disease | 5 (3.9) | ||||
| • Chronic bronchitis | 5 (3.9) | ||||
| • Asthma | 21 (16.5) | ||||
| • Diabetes mellitus | 10 (7.8) | ||||
| • Neurological diseases | 9 (7.1) | ||||
| • Oncological diseases | 14 (11.0) |
N/A = not available, no answer. SD = standard deviation.